SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001628279-22-000012
Filing Date
2022-01-12
Accepted
2022-01-12 13:29:34
Documents
14

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 93156
2 filename2.htm EX-3.1 193906
3 filename3.htm EX-3.3 98322
4 filename4.htm EX-4.1 401621
5 filename5.htm EX-10.1 553821
6 filename6.htm EX-10.13 890118
7 filename7.htm EX-10.14 864370
8 filename8.htm EX-10.15 23989
9 filename9.htm EX-10.16 24194
10 filename10.htm EX-10.17 85215
11 filename11.htm EX-10.18 55827
12 filename12.htm EX-10.19 10988
13 filename13.htm EX-21.1 2378
14 image_0a.jpg GRAPHIC 521
  Complete submission text file 0001628279-22-000012.txt   3299727
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-05831 | Film No.: 22526198
SIC: 2836 Biological Products, (No Diagnostic Substances)